Health Condition 1: N801- Endometriosis of ovary
Conditions
Interventions
Intervention1: Dienogest Arm: Serum AMH levels are seen before Dienogest therapy, immediately after completion of 3 months therapy and 3 months after stopping therapy.
dienogest is given in 2 mg oral
Sponsors
AIIMS New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. diagnosed with endometriotic cyst by clinical examination and ultrsound 2. ovarian endometrioma <6cm
Exclusion criteria
Exclusion criteria: 1.history of hormonal treatment in the past 3 mnoths 2.FSH >15 mIU/ml 3. pregnancy 4. post menopausal 5. prevoius ovarian surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in AMH levels after Dienogest therapy vs surgeryTimepoint: Change in AMH levels after Dienogest therapy vs surgery Dienogest group- 0,3,6 months Surgery group- Before surgery,2 weeks after surgery,3 months after surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To study and compare the reduction in pain related symptoms within 3 mnoths 2. To study and compare the effects of 3 months Dienogest therapy vs Endometriotic Cystectomy on Antral Follicle Count To assess and compare Spontaneous Conception rates after Dienogest Therapy vs surgery To assess the quanitative reduction in cyst size after Dienogest therapy vs surgeryTimepoint: 3 months | — |
Countries
India
Contacts
Public Contactkumari akanksha pandey
AIIMS, New Delhi
Outcome results
None listed